FOUNDERS

GT brings together the complementary expertise of Dr. Justin Prien and Dr. Anthony Lapadula. Dr. Prien is an expert in Glycome Technologies Inc.'s core methodology, ion trap MSⁿ carbohydrate analysis. His previous work focused on the benefits of ion trap MSⁿ in cancer biomarker discovery and differentiating isomeric structures from complex biological mixtures. Dr. Lapadula, following nine years as a software design engineer, lead, and development manager at Microsoft Corporation, began developing glycan analysis software in 2002. Drs. Prien and Lapadula were previously members of the Glycomics Center at the University of New Hampshire.